We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Alpha Tau Medical focuses on R&D, and commercialization of Alpha DaRT (Diffusing Alpha-emitters Radiation Therapy) for the treatment of solid cancer tumors. The Alpha DaRT technology was developed in 2003 at Tel Aviv University. Alpha Tau Medical focuses on R&D, and commercialization of Alpha DaRT (Diffusing Alpha-emitters Radiation Therapy) for the treatment of solid cancer tumors. The Alpha DaRT technology was developed in 2003 at Tel Aviv University.
JERUSALEM, March 25, 2024 (GLOBE NEWSWIRE) -- Alpha Tau Medical Ltd. ("Alpha Tau", or the “Company”) (NASDAQ: DRTS, DRTSW), the developer of the innovative alpha-radiation cancer therapy Alpha...
- Positive interim safety and feasibility data from pancreatic cancer study in Montreal, with initial signs of potential dose response findings - - ReSTART U.S. multi-center pivotal trial...
JERUSALEM, Feb. 26, 2024 (GLOBE NEWSWIRE) -- Alpha Tau Medical Ltd. ("Alpha Tau", or the “Company”) (NASDAQ: DRTS, DRTSW), the developer of the innovative alpha-radiation cancer therapy Alpha...
- The overview presentation will review some of the Company’s recent achievements, including highly promising interim results from the Company’s pancreatic cancer safety and feasibility trial as...
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | -0.25 | -8.89679715302 | 2.81 | 2.9 | 2.55 | 49595 | 2.71057243 | CS |
4 | -0.66 | -20.4968944099 | 3.22 | 3.22 | 2.55 | 36757 | 2.84095603 | CS |
12 | -0.58 | -18.4713375796 | 3.14 | 3.4 | 2.55 | 30034 | 2.97697273 | CS |
26 | -0.95 | -27.0655270655 | 3.51 | 3.6499 | 2.55 | 32876 | 3.01166685 | CS |
52 | -0.48 | -15.7894736842 | 3.04 | 4.8001 | 2.55 | 45329 | 3.48183709 | CS |
156 | -8.99 | -77.8354978355 | 11.55 | 20.65 | 2.55 | 112615 | 9.47311272 | CS |
260 | -8.99 | -77.8354978355 | 11.55 | 20.65 | 2.55 | 112615 | 9.47311272 | CS |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions